Abstract
Intravenous Ketorolac versus Intravenous Morphine for the management of severe vaso-occlusive pain crisis in children with sickle cell disease, an open label randomised controlled trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have